cAMP-dependent protein kinase a is required for Schwann cell growth: Interactions between the cAMP and neuregulin/tyrosine kinase pathways

Journal of Neuroscience Research

Volumn 49, Issue 2, 1997, Pages 236-247

  Kim, Haesun A ^a,c   DeClue, Jeffrey E ^b   Ratner, Nancy ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Forskolin; H 89; MAP kinase; Proliferation; Raf

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; NEU DIFFERENTIATION FACTOR; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; ENZYME REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SCHWANN CELL;

ANIMALS; CELL CYCLE; CELL DIVISION; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME INHIBITORS; GLIA MATURATION FACTOR; GLYCOPROTEINS; HUMANS; ISOQUINOLINES; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEUREGULINS; NEURONS; PROTEIN-TYROSINE KINASES; RATS; RECOMBINANT PROTEINS; SCHWANN CELLS; STIMULATION, CHEMICAL; SULFONAMIDES;

EID: 0030791708     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19970715)49:2<236::AID-JNR12>3.0.CO;2-Z     Document Type: Article

References (77)

1. Boyle WJ, van der Geer P, Hunter T (1991): Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol 201:110-149.
2. Bradley WG, Asbury AK (1970): Duration of synthesis phase in neuilemma cells in mouse sciatic nerve during degeneration. Exp Neurol 26:275-282.
3. Brockes JP, Fields KL, Raff MC (1979): Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res 165:105-118.
4. Brockes JP, Lemke GE, Balzer DR Jr (1980): Purification and preliminary characterization of a glial growth factor from the bovine pituitary. J Biol Chem 255:8374-8377.
5. Bunge MB, Bunge RP, Carey DJ, Cornbrooks CJ, Eldridge CF, Williams AK, Wood PM (1983): Axonal and non-axonal influences on Schwann cells development. In Coates PW, Markwald RR, Kenny (eds): "Development and Regenerating Vertebrate Nervous Systems." New York: Alan R. Liss, pp. 71-105.
6. Burgering BMT, Pronk GJ, van Weeren PC, Chardin P, Bos JL (1993): cAMP antagonize p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO 12:4211-4220.
7. Carlsen RC (1982): Axonal transport of adenylate cyclase activity in normal and axotomized frog sciatic nerve. Brain Res 232:413-424.
8. Cassel D, Wood PM, Bunge RP, Glaser L (1982): Mitogenicity of brain axolemma membranes and soluble factors for dorsal root ganglion Schwann cells. J Cell Biochem 18:433-445.
9. Chen J-K, Yao L-L, Jenq C-B (1991): Mitogenic response of rat Schwann cells to fibroblast growth factors is potentiated by increased intracellular cyclic AMP levels. J Neurosci 30:321-327.
10. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaka H (1990): Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase. N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265:5267-5272.
11. Cho-Chung YS (1990): Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: New approaches to therapy. Cancer Res 50:7093-7100.
12. Cho-Chung YS, Clair T, Tortora G, Yokozaki H (1991): Role of site-selective cAMP analogs in the control and reversal of malignancy. Pharmacol Ther 50:1-33.
13. Chuang E, Barnard D, Hettich L, Zhang XF, Avruch J, Marshall MS (1994): Critical binding and regulatory interactions between Ras and Raf occur through a small, stable N-terminal domain of Raf and specific Ras effector residues. Mol Cell Biol 14:5318-5325.
14. Cook SJ, McCormick F (1993): Inhibition by cAMP of ras-dependent activation of raf. Science 262:1069-1072.
15. Cowley S, Paterson H, Kemp P, Marshall CJ (1994): Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH3T3 cells. Cell 77:841-852.
16. Crespo P, Xu N, Daniotti JL, Troppmair J, Rapp UR, Gutkind JS (1994): Signaling through transforming G protein-coupled receptors in NIH 3T3 cells involves c-Raf activation. Evidence for a protein kinase C-independent pathway. J Biol Chem 269:21103-21109.
17. Davis JB, Stroobant P (1990): Platelet-derived growth factors and fibroblast growth factors are mitogenic for rat Schwann cells. J Cell Biol 110:1353-1360.
18. de Vries-Smits AMM, Brugering BMT, Leevers SJ, Marshall CJ, Bos JL (1992): Involvement of p21ras in activation of extracellular signal-regulated kinase 2. Nature 357:602-604.
19. Dent P, Haser W, Haystead TA, Vincent LA, Roberts TM, Sturgill TW (1992): Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. Science 257:1404-1407.
20. Dumont JE, Jauniaux JC, Roger PP (1989): The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem Sci 14:67-71.
21. Eccleston PA, Collarini EJ, Mirsky R, Jessen KR, Richardson WD (1990): Platelet derived growth factor stimulates Schwann cell DNA synthesis. Neuroscience 2:985-992.
22. Ekstrom PA, Bergstrand H, Edstrom A (1992): Effects of protein kinase inhibitors on regeneration in vitro of adult frog sciatic sensory axons. J Neurosci Res 31:462-469.
23. Franks KJ, Whitfield JF, Durkin P (1985): The mitogenic/oncogenic p21 Ki-Ras protein stimulates adenylate cyclase activity early in the G1 phase of MRK rat kidney cells. Biochem Biophys Res Commun 132:780-786.
24. Frodin M, Peraldi P, Van Obberghen E (1994): Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. J Biol Chem 269:6207-6214.
25. Gagelin C, Pierre M, Toru-Delbauffe D (1994): Inhibition of G1 cyclin expression and G1 cyclin-dependent protein kinases by cAMP in an astrocytic cell line. Biochem Biophys Res Comm 205:923-929.
26. Gallego C, Gupta SK, Heasley LE, Qian NX, Johnson GL (1992): Mitogen-activated protein kinase activation resulting from selective oncogene expression in NIH3T3 and Rat la cells. Proc Natl Acad Sci USA 89:7355-7359.
27. Graves LM, Bornfeldt KE, Raines EW, Potts BC, Macdonald SG, Ross R, Krebs EG (1993): Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc Nat Acad Sci USA 90:10300-10304.
28. Graves LM, Bornfeldt KE, Sidhu JS, Argast GM, Raines EW, Ross R, Leslie CC, Krebs EG (1996): Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells. J Biol Chem 271:505-511.
29. Hafner S, Adler HS, Mischak H, Janosch P, Heidecker G, Wolfman A, Pippig S, Lohse M, Ueffing M, Kolch W (1994): Mechanism of inhibition of Raf-1 by protein kinase A. Mol Cell Biol 14:6696-6703.
30. Hagag N, Halegoua S, Viola M (1986): Inhibition of growth factor-induced differentiation of PC12 cells by microinjection of antibody to ras p21. Nature 319:680-682.
31. Haystead CM, Gregory P, Shirazi A, Fadden P, Mosse C, Dent P, Haystead TA (1994): Insulin activates a novel adipocyte mitogen-activated protein kinase kinase kinase that shows rapid phasic kinetics and is distinct from c-Raf. J Biol Chem 269:12804-12808.
32. Hidaka H, Inagaki M, Kawamoto S, Sasaki Y (1984): Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23:5036-5041.
33. Howe LR, Leevers SJ, Gomez N, Nakielny S, Cohen P, Marshall CJ (1992): Activation of the MAP kinase pathway by the protein kinase raf. Cell 71:335-342.
34. Kim HA, Rosenbaum T, Marchionni MA, Ratner N, DeClue JE (1995): Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes. Oncogene 11:325-335.
35. Krasnoselsky A, Massay MJ, DeFrances MC, Michalopoulos G, Zarnegar R, Ratner N (1994): Hepatocyte growth factor is a mitogen for Schwann cells and is present in neurofibromas. J Neurosci 14:7284-7290.
36. Krebs EG, Beavo JA (1972): Phosphorylation-dephosphorylation of enzymes. A. Rev Biochem 48:923-939.
37. Kremer NE, D'Arcangelo G, Thomas SM, DeMarco M, Brugge JS, Halegoua S (1991): Signal transduction by nerve growth factor and fibroblast growth factor in PC12 cells requires a sequence of src and ras actions. J Cell Biol 115:809-819.
38. Leevers SJ, Paterson HF, Marshall CJ (1994): Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369:411-414.
39. Lemke GE, Brockes JP (1984): Identification and purification of glial growth factor. J Neurosci 4:75-83.
40. Levi AD, Bunge RP, Lofgren JA, Meima L, Hefti F, Nikolics K, Sliwkowski MX (1995): The influence of heregulins on human Schwann cell proliferation. J Neurosci 15:1329-1340.
41. Marchionni MA, Goodearl ADJ, Chen MS, Bermingham-McDonogh O, Kirk C, Hendricks M, Danehy F, Misumi D, Sudhalter J, Kobayashi K, Wroblewski D, Lynch C, Baldasare M, Hiles I, Davis JB, Hsuan JJ, Totty NF, Otsu M, McBurney RN, Waterfield MD, Stroobant P, Gwynne D (1993): Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system [see comments]. Nature 362:312-318.
42. Meador-Woodruff JH, Lewis BL, DeVries GH (1984): Cyclic AMP and calcium as potential mediators of stimulation of cultured Schwann cell proliferation by axolemma-enriched and myelin-enriched membrane fractions. Biochem Biophys Res Commun 122:373-380.
43. Miyazaki M, Wahid S, Bai L, Namba M (1992): Effects of intracellular cyclic AMP and cyclic GMP levels on DNA synthesis of young-adult rat hepatocytes in primary culture. Exp Cell Res 200:404-409.
44. Monuki ES, Weinmaster G, Kuhn R, Lemke G (1989): SCIP: A glial cell POU domain gene regulated by cyclic AMP. Neuron 3:783-793.
45. Morrissey TK, Levi AD, Nuijens A, Sliwkowski MX, Bunge RP (1995): Axon-induced mitogenesis of human Schwann cells involves heregulin and p185erbB2. Proc Natl Acad Sci USA 92:1431-1435.
46. Nordlund M, Hong D, Fei X, Ratner N (1992): Schwann cells and cells in the oligodendrocyte lineage proliferate in response to a 50,000 dalton membrane-associated mitogen present in developing brain. Glia 5:182-192.
47. Olson EN, Spizz G, Tainsky MA (1987): The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol Cell Biol 7:2104-2111.
48. Orr-Urtreger A, Trakhtenbrot L, Ben-Levy R, Wen D, Rechavi G, Lonai P, Yarden Y (1993): Neural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21. Proc Natl Acad Sci USA 90:1867-1871.
49. Peraldi P, Frodin M, Barnier JV, Calleja V, Scimeca JC, Filloux C, Calothy G, Van Obberghen E (1995): Regulation of the MAP kinase cascade in PC12 cells: B-Raf activates MEK-1 (MAP kinase or ERK kinase) and is inhibited by cAMP. FEBS Lett 357:290-296.
50. Porras A, Muszynski K, Rapp UR, Santos E (1994): Dissociation between activation of Raf-1 kinase and the 42-kDa mitogen-activated protein kinase/90-kDa S6 kinase (MAPK/RSK) cascade in the insulin/Ras pathway of adipocytic differentiation of 3T3 L1 cells. J Biol Chem 269:12741-12748.
51. Qui MS, Green SH (1992): PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity. Neuron 9:705-717.
52. Raff MC, Abney E, Brockes JP, Hornby-Smith A (1978a): Schwann cell growth factors. Cell 15:813-822.
53. Raff MC, Hornby-Smith A, Brockes JP (1978b): Cyclic AMP as a mitogenic signal for cultured rat Schwann cells. Nature 273:672-673.
54. Ratner N, Glaser L, Bunge RP (1984): PC12 cells as a source of neurite-derived cell surface mitogen, which stimulates Schwann cell division. J Cell Biol 98:1150-1155.
55. Ratner N, Bunge RP, Glaser L (1985): A neuronal cell surface heparan sulfate proteoglycan is required for dorsal root ganglion neuron stimulation of Schwann cell proliferation. J Cell Biol 101:744-754.
56. Ratner N, Elbein A, Bunge MB, Porter S, Bunge RP, Glaser L (1986): Specific asparagine-linked oligosaccharides are not required for certain neuron-neuron and neuron-Schwann cell interactions. J Cell Biol 103:159-170.
57. Ridley AJ, Paterson HF, Noble M, Land H (1988): Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J 7:1635-1645.
58. Romine JS, Bray GM, Aguayo AJ (1976): Schwann cell multiplication after crush injury of unmyelinated fibers. Arch Neurol 33:49-54.
59. Rosenbaum C, Karyala S, Marchionni MA, Kim HA, Krasnoselsky AL, Happel B, Isaacs I, Brackenbury R, Ratner N (1997): Schwann cells express NDF and SMDF/n-ARIA mRNAs, secrete neuregulin, and show constitutive activation of erbB3 receptors: Evidence for an autocrine loop. Exp Neurol, in press.
60. Salzer JL, Bunge RP (1980): Studies of Schwann cell proliferation. I. An analysis in tissue culture of proliferation during development, Wallerian degeneration, and direct injury. J Cell Biol 84:739-752.
61. Salzer JL, Bunge RP, Glaser L (1980a): Studies of Schwann cell proliferation. III. Evidence for the surface localization of the neurite mitogen. J Cell Biol 84:767-778.
62. Salzer JL, Williams AK, Glaser L, Bunge RP (1980b): Studies of Schwann cell proliferation. II. Characterization of the stimulation and specificity of the response to a neurite membrane fraction. J Cell Biol 84:753-766.
63. Santos E, Nebreda AR (1989): Structural and functional properties of ras proteins. FASEB J 3:2151-2163.
64. Schaap D, van der Wal J, Howe LR, Marshall CJ, van Blitterswijk WJ (1993): A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras. J Biol Chem 268:20232-20236.
65. Schubert D (1992): Synergistic interactions between transforming growth factor beta and fibroblast growth factor regulate Schwann cell mitosis. J Neurobiol 23:143-148.
66. Schumacher M, Jung-Testas I, Robel P, Baulieu EE (1993): Insulin-like growth factor I: A mitogen for rat Schwann cells in the presence of elevated levels of cyclic AMP. Glia 8:232-240.
67. Sevetson BR, Kong X, Lawrence C (1993): Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc Natl Acad Sci USA 90:10305-10309.
68. Stewart HJ, Eccleston PA, Jessen KR, Mirsky R (1991): Interaction between cAMP elevation, identified growth factors, and serum components in regulating Schwann cell growth. J Neurosci Res 30:346-352.
69. Stokoe D, Macdonald SG, Cadwallader K, Symons M, Hancock JF (1994): Activation of Raf as a result of recruitment to the plasma membrane. Science 264:1463-1467.
70. Szeberenyi J, Cai H, Cooper GM (1990): Effect of a dominant inhibitory Ha-ras mutation on neuronal differentiation of PC12 cells. Mol Cell Biol 10:5324-5332.
71. Tortora G, Pepe S, Bianco C, Baldassarre G, Budillon A, Clair T, Cho-Chung YS, Bianco AR, Ciardiello F (1994): The RI alpha subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells. Oncogene 9:3233-3240.
72. Weinmaster G, Lemke G (1990): Cell-specific cyclic AMP-mediated induction of the PDGF receptor. EMBO J 9:915-920.
73. White MA, Nicolette C, Minden A, Polverino A, Van Aelst L, Karin M, Wigler MH (1995): Multiple Ras functions can contribute to mammanlian cell transformation. Cell 80:533-541.
74. Wood PM, Bunge RP (1975): Evidence that sensory axons are mitogenic for Schwann cells. Nature 256:662-664.
75. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW (1993): Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5'-monophosphate. Science 262:1065-1069.
76. Yokozaki H, Budillon A, Tortora G, Meissner S, Beaucage SL, Miki K, Cho-Chung YS (1993): An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells. Cancer Res 53:868-872.
77. Zheng CF, Ohmichi M, Saltiel AR, Guan KL (1994): Growth factor induced MEK activation is primarily mediated by an activator different from c-raf. Biochemistry 33:5595-5599.